Thomas Kietzmann Selected Research

trans-2-enoyl-CoA reductase (NADPH)

1/2017

Non-electron transfer chain mitochondrial defects differently regulate HIF-1α degradation and transcription.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Kietzmann Research Topics

Disease

53	Hypoxia (Hypoxemia) 01/2021 - 07/2002
24	Neoplasms (Cancer) 01/2021 - 08/2004
10	Carcinogenesis 09/2020 - 09/2002
8	Inflammation (Inflammations) 01/2021 - 03/2005
5	Hepatocellular Carcinoma (Hepatoma) 08/2010 - 06/2005
4	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 08/2004
3	Ischemia 01/2016 - 04/2008
3	Vascular Remodeling 08/2010 - 03/2004
3	Thrombosis (Thrombus) 08/2004 - 11/2002
2	Insulin Resistance 01/2019 - 12/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 09/2006
2	Fibrosis (Cirrhosis) 01/2016 - 12/2015
2	Obesity 01/2015 - 01/2013
2	Hyperinsulinism (Hyperinsulinemia) 08/2007 - 12/2006
2	Pulmonary Hypertension 06/2005 - 03/2004
2	Atherosclerosis 08/2004 - 08/2004
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Thymoma (Thymic Carcinoma) 09/2020
1	Carcinoma (Carcinomatosis) 09/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Alcoholic Fatty Liver 01/2019
1	Fatty Liver 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Disease Progression 10/2017
1	Adenocarcinoma 02/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2015

Drug/Important Bio-Agent (IBA)

22	Transcription Factors (Transcription Factor)IBA 12/2020 - 07/2002
22	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2003
15	Plasminogen Activator Inhibitor 1IBA 01/2016 - 02/2003
13	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 08/2004
13	Plasminogen Activators (Plasminogen Activator)IBA 01/2013 - 02/2003
11	Oxygen (Dioxygen)IBA 12/2020 - 09/2002
10	Messenger RNA (mRNA)IBA 01/2019 - 02/2003
8	AntioxidantsIBA 01/2019 - 07/2008
8	EnzymesIBA 01/2019 - 07/2002
5	Insulin (Novolin)FDA Link 05/2010 - 02/2003
5	ElementsIBA 05/2010 - 09/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2002
4	Phosphotransferases (Kinase)IBA 01/2016 - 04/2003
4	LuciferasesIBA 05/2010 - 07/2002
3	LipidsIBA 01/2019 - 12/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 12/2015
3	ChromatinIBA 01/2017 - 12/2007
3	Superoxide DismutaseIBA 01/2017 - 08/2014
3	ResveratrolIBA 01/2016 - 01/2013
3	CytokinesIBA 01/2015 - 03/2005
2	Hormones (Hormone)IBA 01/2021 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2017
2	Polysaccharides (Glycans)IBA 01/2021 - 01/2019
2	Erythropoietin FDA Link 12/2020 - 09/2005
2	UbiquitinIBA 01/2019 - 02/2012
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019 - 12/2004
2	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 11/2015
2	ErbB Receptors (EGF Receptor)IBA 02/2017 - 02/2016
2	CateninsIBA 01/2017 - 11/2015
2	Upstream Stimulatory FactorsIBA 01/2016 - 01/2015
2	Protein Kinases (Protein Kinase)IBA 01/2016 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 03/2005
2	Glycogen Synthase Kinase 3IBA 02/2012 - 05/2007
2	Pharmaceutical PreparationsIBA 01/2009 - 08/2006
2	Heme Oxygenase-1IBA 07/2008 - 03/2005
2	Deferoxamine (Desferal)FDA LinkGeneric 12/2005 - 09/2005
2	Chelating AgentsIBA 12/2005 - 12/2004
2	Thrombin FDA Link 06/2005 - 03/2004
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	GlycoconjugatesIBA 01/2021
1	CarcinogensIBA 10/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2020
1	GlycogenIBA 09/2020
1	TOR Serine-Threonine KinasesIBA 09/2020
1	Cyclin-Dependent Kinase 5IBA 04/2019
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	SialyltransferasesIBA 01/2019
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2019
1	Protein Disulfide-IsomerasesIBA 01/2019
1	DisulfidesIBA 01/2019
1	LectinsIBA 01/2019
1	Carcinoembryonic AntigenIBA 01/2019
1	GlycolipidsIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	ParaffinIBA 01/2019
1	Ubiquitin-Specific ProteasesIBA 01/2018
1	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 02/2017
1	Untranslated RNA (Noncoding RNA)IBA 01/2017
1	trans-2-enoyl-CoA reductase (NADPH)IBA 01/2017
1	Fatty Acid DesaturasesIBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	arseniteIBA 10/2016
1	PlasminogenIBA 02/2016
1	Epidermal Growth Factor (EGF)IBA 02/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 02/2016
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2016
1	Oxidants (Oxidizing Agents)IBA 12/2015

Therapy/Procedure

4	Therapeutics 01/2019 - 08/2006
1	Drug Therapy (Chemotherapy) 10/2015